Skip to content

A Randomized Controlled Clinical Trial on Exocarpium Citri Grandis Phlegm Cough Solution Alleviating the Symptoms of Community-Acquired Pneumonia (CAP) in Adults

A Randomized Controlled Clinical Trial on Exocarpium Citri Grandis Phlegm Cough Solution Alleviating the Symptoms of Community-Acquired Pneumonia (CAP) in Adults

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039125
Enrollment
Unknown
Registered
2020-10-17
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired Pneumonia

Interventions

Sponsors

Maoming People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 80 years; 2. Those patients diagnosed with community-acquired pneumonia according to the diagnostic criteria of Chinese guidelines for the diagnosis and treatment of community-acquired pneumonia for adults 2018; 3. Patients with cough, expectoration or asthma; 4. Patients who can take medicine orally; 5. The patient or his legal representative voluntarily participated in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with pregnant or lactating women; 2. Patients who had allergic reaction to Juhong expectoration liquid in the past; 3. Patients who can't cooperate with BCSS score and VAS score (such as disturbance of consciousness, mental retardation, etc.); 4. Patients with severe systemic diseases (such as malignant tumor, autoimmune disease, liver or kidney disease) or surgery (organ transplantation, splenectomy); 5. Patients who are participating in clinical trials of other drugs; 6. Any other situation that the researcher thinks is not suitable to participate in the clinical trial (such as increasing the risk of the subject or interfering with the judgment of the end point of the study, etc.).

Design outcomes

Primary

MeasureTime frame
BCSS scale and VAS scale;

Secondary

MeasureTime frame
length of hospital stay;In-hospital mortality;

Countries

China

Contacts

Public ContactChunbo Chen

Maoming People's Hospital

gghccm@163.com+86 668-2922871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026